Cass ND, Schopper MA, Lubin JA, Fishbein L, Gubbels SP (2020) The changing paradigm of head and neck paragangliomas: what every otolaryngologist needs to know. Annals Otology Rhinology Laryngology 129:1135–1143

Article  Google Scholar 

Lin EP, Chin BB, Fishbein L, Moritani T, Montoya SP, Ellika S et al (2022) Head and Neck paragangliomas: an update on the molecular classification, state-of-the-art imaging, and Management recommendations. Radiol Imaging Cancer 4:e210088

Article  PubMed  PubMed Central  Google Scholar 

Richter S, Qiu B, Ghering M, Kunath C, Constantinescu G, Luths C et al (2022) Given the potential hereditary component, genetic counseling and testing are necessary Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine. Endocr Relat Cancer 29:213–224

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taïeb D, Imperiale A, Pacak K (2016) (18)F-DOPA: the versatile radiopharmaceutical. Eur J Nucl Med Mol Imaging 43:1187–1189

Article  PubMed  PubMed Central  Google Scholar 

Castinetti F, Kroiss A, Kumar R, Pacak K, Taieb D (2015) 15 YEARS OF PARAGANGLIOMA: imaging and imaging-based treatment of pheochromocytoma and paraganglioma. Endocr Relat Cancer 22:T135–T145

Article  CAS  PubMed  Google Scholar 

Amodru V, Guerin C, Delcourt S, Romanet P, Loundou A, Viana B et al (2018) Quantitative (18)F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype. Eur J Nucl Med Mol Imaging 45:278–282

Article  PubMed  Google Scholar 

Moog S, Houy S, Chevalier E, Ory S, Weryha G, Rame M et al (2018) 18F-FDOPA PET/CT uptake parameters correlate with catecholamine secretion in human pheochromocytomas. Neuroendocrinology 107:228–236

Article  CAS  PubMed  Google Scholar 

Taïeb D, Jha A, Treglia G, Pacak K (2019) Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups. Endocr Relat Cancer 26:R627–R652

Article  PubMed  PubMed Central  Google Scholar 

Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B et al (2009) Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 94:4757–4767

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gabriel S, Blanchet EM, Sebag F, Chen CC, Fakhry N, Deveze A et al (2013) Functional characterization of no metastatic paraganglioma and pheochromocytoma by (18)F-FDOPA PET: focus on missed lesions. Clin Endocrinol 79:170–177

Article  CAS  Google Scholar 

Reichert T, Fakhry N, Lavieille JP, Amodru V, Sebag F, Romanet P et al (2019) Exploring the link between tumour metabolism and succinate dehydrogenase deficiency: a 18 F-FDOPA PET/CT study in head and neck paragangliomas. Clin Endocrinol (Oxf) 91:879–884

Article  CAS  PubMed  Google Scholar 

Hatt M, Le Rest CC, Tixier F, Badic B, Schick U, Visvikis D (2019) Radiomics: Data are also images. J Nucl Med 60:38S–44S

Article  PubMed  Google Scholar 

Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A (2022) Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol 19:132–146

Article  CAS  PubMed  Google Scholar 

Li S, Zhou B (2022) A review of radiomics and genomics applications in cancers: the way towards precision medicine. Radiat Oncol 17:217

Article  PubMed  PubMed Central  Google Scholar 

Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P et al (2022) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446

Article  Google Scholar 

Ansquer C, Drui D, Mirallié E, Renaudin-Autain K, Denis A, Gimenez-Roqueplo AP et al (2020) A usefulness of FDG-PET/CT-Based Radiomics for the characterization and genetic orientation of Pheochromocytomas before surgery. Cancers (Basel) 12(9):2424. https://doi.org/10.3390/cancers12092424

Noortman WA, Vriens D, de Geus-Oei LF, Slump CH, Aarntzen EH, van Berkel A et al (2022) [18F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas. Eur Radiol 32:7227–7236

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taïeb D, Hicks RJ, Hindié E, Guillet BA, Avram A, Ghedini P et al (2019) European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 46:2112–2137

Article  PubMed  PubMed Central  Google Scholar 

Nioche C, Orlhac F, Boughdad S, Reuzé S, Goya-Outi J, Robert C et al (2018) LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res 78:4786–4789

Article  CAS  PubMed  Google Scholar 

Orlhac F, Boughdad S, Philippe C, Stalla-Bourdillon H, Nioche C, Champion L et al (2018) Postreconstruction Harmonization Method for Multicenter Radiomic studies in PET. J Nucl Med 59:1321–1328

Article  CAS  PubMed  Google Scholar 

Toledo RA, Burnichon N, Cascon A, Benn DE, Bayley JP, Welander J et al (2017) Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol 13:233–247

Article  CAS  PubMed  Google Scholar 

Zhi Y, Gerhard-Hartmann E, Hartrampf PE, Weich A, Higuchi T, Bley TA et al (2023) Somatostatin receptor-Directed PET/CT can differentiate between different subtypes of Head and Neck Paragangliomas. Clin Nucl Med 433:48:923–927

Article  Google Scholar 

Pepponi M, Berti V, Fasciglione E, Montanini F, Canu L, Hubele F et al (2024) [68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation. Eur J Nucl Med Mol Imaging. 51(9):2684–2694. https://doi.org/10.1007/s00259-024-06735-5

van Berkel A, Vriens D, Visser EP, Janssen MJR, Gotthardt M, Hermus ARMM et al (2019) Metabolic subtyping of Pheochromocytoma and Paraganglioma by (18)F-FDG pharmacokinetics using dynamic PET/CT scanning. J Nucl Med 60:745–751

Article  PubMed  PubMed Central  Google Scholar 

De Rycke O, Perrier M, Ouvrard É, Mennetrey C, Lachachi C, Bando-Delaunay A et al (2023) High Tumor Uptake on 18F-FDOPA PET/CT indicates poor prognosis in patients with metastatic midgut neuroendocrine tumors: a study from the Groupe d’étude Des Tumeurs endocrines and ENDOCAN-RENATEN Network. J Nucl Med 64:1699–1705

Article  PubMed  Google Scholar